ABVC

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

ABVC Biopharma Inc

NASDAQ | ABVC

2.55

USD

$0.00

(

0.00%

)

At Close (As of Dec 2, 2025)

$63.43M

Market Cap

-

P/E Ratio

-0.28

EPS

$5.48

52 Week High

$0.40

52 Week Low

HEALTHCARE

Sector

ABVC Chart

Recent Chart
Price Action

ABVC Technicals

Tags:

ABVC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $509K
Total Revenue $510K
Cost Of Revenue $763
Costof Goods And Services Sold $763
Operating Income -$4.7M
Selling General And Administrative $5M
Research And Development $179K
Operating Expenses $5.2M
Investment Income Net -
Net Interest Income -$739K
Interest Income $87K
Interest Expense $826K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $201K
Income Before Tax -$5.4M
Income Tax Expense -$111K
Interest And Debt Expense -
Net Income From Continuing Operations -$5.3M
Comprehensive Income Net Of Tax -
Ebit -$4.5M
Ebitda -$4.3M
Net Income -$4.9M

Revenue & Profitability

Earnings Performance

ABVC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $7.5M
Total Current Assets $2.2M
Cash And Cash Equivalents At Carrying Value $864K
Cash And Short Term Investments $864K
Inventory -
Current Net Receivables $1.2M
Total Non Current Assets $5.4M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $2.3M
Short Term Investments $65K
Other Current Assets $96K
Other Non Current Assets -
Total Liabilities $6.8M
Total Current Liabilities $6.6M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt $3M
Total Non Current Liabilities $258K
Capital Lease Obligations $640K
Long Term Debt -
Current Long Term Debt $1.8M
Long Term Debt Noncurrent -
Short Long Term Debt Total $3.2M
Other Current Liabilities $3.5M
Other Non Current Liabilities $22K
Total Shareholder Equity $1.2M
Treasury Stock -
Retained Earnings -$69M
Common Stock $14K
Common Stock Shares Outstanding $12M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$1.8M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $201K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $2M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$7.3K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$5.3M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $509K
Total Revenue $510K
Cost Of Revenue $763
Costof Goods And Services Sold $763
Operating Income -$4.7M
Selling General And Administrative $5M
Research And Development $179K
Operating Expenses $5.2M
Investment Income Net -
Net Interest Income -$739K
Interest Income $87K
Interest Expense $826K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $201K
Income Before Tax -$5.4M
Income Tax Expense -$111K
Interest And Debt Expense -
Net Income From Continuing Operations -$5.3M
Comprehensive Income Net Of Tax -
Ebit -$4.5M
Ebitda -$4.3M
Net Income -$4.9M

ABVC News

ABVC Profile

ABVC Biopharma Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

ABVC Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies and medical devices that target significant unmet medical needs, primarily within the U.S. market. With a robust and diverse pipeline that encompasses both therapeutic agents and advanced drug delivery systems, ABVC is committed to improving patient outcomes across various disease indications. The company leverages cutting-edge technologies and strategic partnerships to enhance its development capabilities, positioning itself as a promising player in the biopharmaceutical sector with substantial growth potential and a commitment to impactful healthcare solutions.

LPTX
+368.57%
$2.05
PAVS
-29.35%
$0.05
BYND
-3.73%
$1.29
NVDA
+0.85%
$181.46
INTC
+8.64%
$43.47
PLRZ
+131.96%
$7.33
VHAI
0.00%
$0.00
FTEL
-0.83%
$1.19
PLUG
+9.89%
$2.11
CMND
-9.93%
$0.12
TWOH
0.00%
$0.00
BITF
-5.48%
$3.10
ONDS
+6.46%
$8.07
IREN
-15.19%
$41.12
IPG
-1.95%
$24.57
TSLA
-0.20%
$429.24
AXDX
-61.36%
$0.03
AAL
+2.00%
$14.24
ASST
-1.42%
$1.03
BMNR
+10.26%
$31.91
SOFI
+1.65%
$29.51
F
-1.51%
$12.96
BBD
+1.38%
$3.67
AAPL
+1.09%
$286.19
ADAP
-15.14%
$0.05
WBD
+2.76%
$24.53
BAC
-0.09%
$53.19
AMZN
+0.23%
$234.42
MARA
+3.38%
$11.91
ACHR
+2.54%
$7.65
DNN
+2.77%
$2.59
PFE
-0.47%
$25.15
NIO
-2.89%
$5.03
SOND
-23.45%
$0.12
BMNU
+19.54%
$7.34
AMD
-2.05%
$215.24
CAN
+2.04%
$0.96
YGMZ
-21.06%
$0.08
CLSK
-2.62%
$13.71
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ABEV
+0.38%
$2.58
BTBT
-0.44%
$2.24
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
ITUB
+2.64%
$7.89
CIFR
-10.41%
$17.64
GOOGL
+0.29%
$315.81
PLTR
+1.91%
$170.69
BTG
-3.26%
$4.43
SRM
+53.27%
$10.30
RIVN
+0.40%
$17.23
GRAB
-0.18%
$5.26
APLD
-0.56%
$28.05
EXK
-1.70%
$9.24
INHD
-15.40%
$0.14
WULF
-7.05%
$14.22
BQ
+41.53%
$2.76
MSTR
+5.78%
$181.33
PLTD
-1.83%
$6.96
KVUE
-2.09%
$16.86
SGMO
+3.47%
$0.44
VALE
+1.57%
$12.89
T
-1.04%
$25.52
MRVL
+1.96%
$92.89
HBAN
+0.12%
$16.56
BURU
-0.76%
$0.21
WLGS
-5.57%
$0.04
RGTI
+1.83%
$23.88
MTSR
-0.35%
$70.50
SNAP
-0.26%
$7.62
RIG
-0.91%
$4.31
CRWV
-1.33%
$76.03
PCG
-3.28%
$15.32
HOOD
+2.19%
$125.95
IXHL
+12.12%
$0.39
NFLX
+0.20%
$109.35
GOOG
+0.28%
$316.02
CHR
-0.91%
$0.04
GPUS
+6.45%
$0.28
AFMD
-34.94%
$0.18
VZ
-0.31%
$40.61
BA
+10.14%
$205.38
AG
+2.51%
$15.91
AVGO
-1.16%
$381.57
TMC
+17.74%
$7.40
RIOT
-1.67%
$15.22
STLA
+2.81%
$10.95
SOUN
-2.60%
$11.22
DRCT
-15.28%
$0.10
HL
+2.45%
$17.52
VCIG
+0.95%
$1.06
XYZ
-6.58%
$60.11
NOK
+1.14%
$6.19
VICI
-0.48%
$28.45
QBTS
+5.04%
$22.50
TAOP
+32.71%
$2.84
KO
-1.77%
$70.67
MSFT
+0.66%
$490.00
CGC
-1.76%
$1.11
LPTX
+368.57%
$2.05
PAVS
-29.35%
$0.05
BYND
-3.73%
$1.29
NVDA
+0.85%
$181.46
INTC
+8.64%
$43.47
PLRZ
+131.96%
$7.33
VHAI
0.00%
$0.00
FTEL
-0.83%
$1.19
PLUG
+9.89%
$2.11
CMND
-9.93%
$0.12
TWOH
0.00%
$0.00
BITF
-5.48%
$3.10
ONDS
+6.46%
$8.07
IREN
-15.19%
$41.12
IPG
-1.95%
$24.57
TSLA
-0.20%
$429.24
AXDX
-61.36%
$0.03
AAL
+2.00%
$14.24
ASST
-1.42%
$1.03
BMNR
+10.26%
$31.91
SOFI
+1.65%
$29.51
F
-1.51%
$12.96
BBD
+1.38%
$3.67
AAPL
+1.09%
$286.19
ADAP
-15.14%
$0.05
WBD
+2.76%
$24.53
BAC
-0.09%
$53.19
AMZN
+0.23%
$234.42
MARA
+3.38%
$11.91
ACHR
+2.54%
$7.65
DNN
+2.77%
$2.59
PFE
-0.47%
$25.15
NIO
-2.89%
$5.03
SOND
-23.45%
$0.12
BMNU
+19.54%
$7.34
AMD
-2.05%
$215.24
CAN
+2.04%
$0.96
YGMZ
-21.06%
$0.08
CLSK
-2.62%
$13.71
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ABEV
+0.38%
$2.58
BTBT
-0.44%
$2.24
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
ITUB
+2.64%
$7.89
CIFR
-10.41%
$17.64
GOOGL
+0.29%
$315.81
PLTR
+1.91%
$170.69
BTG
-3.26%
$4.43
SRM
+53.27%
$10.30
RIVN
+0.40%
$17.23
GRAB
-0.18%
$5.26
APLD
-0.56%
$28.05
EXK
-1.70%
$9.24
INHD
-15.40%
$0.14
WULF
-7.05%
$14.22
BQ
+41.53%
$2.76
MSTR
+5.78%
$181.33
PLTD
-1.83%
$6.96
KVUE
-2.09%
$16.86
SGMO
+3.47%
$0.44
VALE
+1.57%
$12.89
T
-1.04%
$25.52
MRVL
+1.96%
$92.89
HBAN
+0.12%
$16.56
BURU
-0.76%
$0.21
WLGS
-5.57%
$0.04
RGTI
+1.83%
$23.88
MTSR
-0.35%
$70.50
SNAP
-0.26%
$7.62
RIG
-0.91%
$4.31
CRWV
-1.33%
$76.03
PCG
-3.28%
$15.32
HOOD
+2.19%
$125.95
IXHL
+12.12%
$0.39
NFLX
+0.20%
$109.35
GOOG
+0.28%
$316.02
CHR
-0.91%
$0.04
GPUS
+6.45%
$0.28
AFMD
-34.94%
$0.18
VZ
-0.31%
$40.61
BA
+10.14%
$205.38
AG
+2.51%
$15.91
AVGO
-1.16%
$381.57
TMC
+17.74%
$7.40
RIOT
-1.67%
$15.22
STLA
+2.81%
$10.95
SOUN
-2.60%
$11.22
DRCT
-15.28%
$0.10
HL
+2.45%
$17.52
VCIG
+0.95%
$1.06
XYZ
-6.58%
$60.11
NOK
+1.14%
$6.19
VICI
-0.48%
$28.45
QBTS
+5.04%
$22.50
TAOP
+32.71%
$2.84
KO
-1.77%
$70.67
MSFT
+0.66%
$490.00
CGC
-1.76%
$1.11
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.